Results 201 to 210 of about 106,545 (283)

Senataxin and DNA-PKcs redundantly promote non-homologous end joining repair of DNA double strand breaks during V(D)J recombination. [PDF]

Sci Adv
Chen BR, Pham T, Reynolds LD, Dang N, Zhang Y, Manalang K, Matos-Rodrigues G, Neidigk JR, Nussenzweig A, Tyler JK, Sleckman BP.   +10 more
europepmc   +1 more source

Chromosomal abnormalities in Ph- cells of patients on imatinib [PDF]

, 2003
Mary Frances McMullin, Mervyn Humphreys, Jenny Byrne, Nigel H. Russell, R Cuthbert, Michael O’Dwyer   +5 more
openalex   +1 more source

<i>MiR-92a-1-5p</i> contributes to cellular proliferation and survival in chronic myeloid leukemia and its inhibition enhances imatinib efficacy. [PDF]

Noncoding RNA Res
Peters J, Bollaert E, Cloos AS, Claus M, Essaghir A, Lenglez S, Saussoy P, Dachy G, Autin P, Demoulin JB, Havelange V.   +10 more
europepmc   +1 more source

Analysis of the impact of imatinib mesylate therapy on the prognosis of patients with Philadelphia chromosome–positive chronic myelogenous leukemia treated with interferon‐α regimens for early chronic phase [PDF]

, 2003
Hagop M. Kantarjian, Susan O’Brien, Jorge E. Cortés, Jianqin Shan, Francis J. Giles, Guillermo Garcia‐Manero, Srđan Verstovšek, Stefan Faderl, Mary Beth Rios, Moshe Talpaz   +9 more
openalex   +1 more source

Imatinib-Induced Recurrent Pleural Effusions. [PDF]

Cureus
Pachika PS, Dande RR, Ngo P.
europepmc   +1 more source

Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis

, 2003
Susan Branford, Zbigniew Rudzki, Sonya Walsh, Ian Parkinson, Andrew Grigg, Jeff Szer, Kerry Taylor, Richard Herrmann, John F. Seymour, Chris Arthur, David Joske, Kevin Lynch, Timothy P. Hughes   +12 more
openalex   +1 more source

Erythema following imatinib mesylate [PDF]

, 2003
Edward Duncan, Kavita Raj, Ghulam Mufti
openalex   +1 more source

Imatinib Mesylate in Cutaneous Melanoma [PDF]

Journal of Investigative Dermatology, 2004
Enrique J. Andreu, Pedro Redondo, Pedro Lloret, Susana Inogés   +3 more
openaire   +3 more sources

Correction: A network-based approach to overcome BCR::ABL1-independent resistance in chronic myeloid leukemia. [PDF]

Cell Commun Signal
Bica V, Venafra V, Massacci G, Graziosi S, Gualdi S, Minnella G, Sorà F, Chiusolo P, Brunetti ME, Napolitano G, Breccia M, Mougiakakos D, Böttcher M, Fischer T, Perfetto L, Sacco F.   +15 more
europepmc   +1 more source

Imatinib (STI571) Provides Only Limited Selectivity for CML Cells and Treatment Might Be Complicated by SilentBCR-ABLGenes [PDF]

, 2003
Guanchao Jiang, Fan Yang, Marilyn M. Li, Karen Weissbecker, Sherrie Price, Chan Kim, Vincent F. La Russa, Hana Safah, Melanie Ehrlich   +8 more
openalex   +1 more source